{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T20:37:41Z","timestamp":1721162261065},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,10]]},"DOI":"10.7759\/cureus.12013","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T16:38:27Z","timestamp":1607618307000},"source":"Crossref","is-referenced-by-count":3,"title":["Paraneoplastic Hypoglycemia in Hepatocarcinoma: Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Carlos A","family":"Regino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"L\u00f3pez-Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernado","family":"L\u00f3pez-Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose C","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Roman-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2573","article-title":"Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung","volume":"92","author":"Nauck MA","year":"2007","unstructured":"Nauck MA, Reinecke M, Perren A, et al.. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab. 2007, 92:1600-1605. 10.1210\/jc.2006-2573","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","article-title":"Hypoglycaemia in hepatocellular carcinoma: a review","volume":"3","author":"Yeung R","year":"1997","unstructured":"Yeung R. Hypoglycaemia in hepatocellular carcinoma: a review. Hong Kong Med J. 1997, 3:297-301.","journal-title":"Hong Kong Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.427_h.x","article-title":"A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection","volume":"93","author":"Saigal S","year":"1998","unstructured":"Saigal S, Nandeesh HP, Malhotra V, Sarin SK. A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol. 1998, 93:1380-1381. 10.1111\/j.1572-0241.1998.427_h.x","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7465025","article-title":"Intractable fasting hypoglycemia as a manifestation of hepatocellular carcinoma","volume":"2017","author":"Forde JJ","year":"2017","unstructured":"Forde JJ, Ewelukwa O, Brar T, Cabrera R. Intractable fasting hypoglycemia as a manifestation of hepatocellular carcinoma. Case Reports Hepatol. 2017, 2017:1-3. 10.1155\/2017\/7465025","journal-title":"Case Reports Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-009-9300-1","article-title":"Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography imaging","volume":"37","author":"Habra MA","year":"2010","unstructured":"Habra MA, N\u00fa\u00f1ez R, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C. Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography imaging. Endocrine. 2010, 37:209-212. 10.1007\/s12020-009-9300-1","journal-title":"Endocrine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411011","article-title":"Tumor-induced hypoglycemia","volume":"341","author":"Le Roith D","year":"1999","unstructured":"Le Roith D. Tumor-induced hypoglycemia. N Engl J Med. 1999, 341:757-758. 10.1056\/NEJM199909023411011","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2013.07.002","article-title":"Transarterial chemoembolization for palliation of paraneoplastic hypoglycemia in a patient with advanced hepatocellular carcinoma","volume":"24","author":"Whitsett M","year":"2013","unstructured":"Whitsett M, Lindenmeyer CC, Shaw CM, Civan JM, Fenkel JM. Transarterial chemoembolization for palliation of paraneoplastic hypoglycemia in a patient with advanced hepatocellular carcinoma. J Vasc Interv Radiol. 2013, 24:1918-1920. 10.1016\/j.jvir.2013.07.002","journal-title":"J Vasc Interv Radiol"},{"key":"ref8","article-title":"Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake","volume":"88","author":"Thipaporn T","year":"2005","unstructured":"Thipaporn T, Bubpha P, Varaphon V. Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake. J Med Assoc Thai. 2005, 88:1941-1946.","journal-title":"J Med Assoc Thai"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.172","article-title":"Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions","volume":"28","author":"Gualberto A","year":"2009","unstructured":"Gualberto A, Pollak M. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene. 2009, 28:3009-3021. 10.1038\/onc.2009.172","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(91)90232-L","article-title":"Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements","volume":"40","author":"Wing JR","year":"1991","unstructured":"Wing JR, Panz VR, Joffe BI, Kalk WJ, Seftel HC, Zapf J, Kew MC. Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements. Metabolism. 1991, 40:508-512. 10.1016\/0026-0495(91)90232-L","journal-title":"Metabolism"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050422","article-title":"A 67-year-old woman with recurrent hypoglycemia: non-islet cell tumour hypoglycemia","volume":"173","author":"Ma RCW","year":"2005","unstructured":"Ma RCW, Tong PCY, Chan JCN, Cockram CS, Chan MHM. A 67-year-old woman with recurrent hypoglycemia: non-islet cell tumour hypoglycemia. CMAJ. 2005, 173:359-361. 10.1503\/cmaj.050422","journal-title":"CMAJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1956.00250300038006","article-title":"Hypoglycemia in primary carcinoma of the liver","volume":"98","author":"McFadzean AJS","year":"1956","unstructured":"McFadzean AJS, Tse YT. Hypoglycemia in primary carcinoma of the liver. AMA Arch Intern Med. 1956, 98:720-731. 10.1001\/archinte.1956.00250300038006","journal-title":"AMA Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196108032650506","article-title":"Hypoglycemia and polycythemia associated with primary hepatoma","volume":"265","author":"Schonfeld A","year":"1961","unstructured":"Schonfeld A, Babbott D, Gundersen K. Hypoglycemia and polycythemia associated with primary hepatoma. N Engl J Med. 1961, 265:231-233. 10.1056\/NEJM196108032650506","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1992.tb00563.x","article-title":"Primary hepatocellular carcinoma with severe hypoglycemia; involvement of insulin-like growth factors","volume":"12","author":"Yonei Y","year":"1992","unstructured":"Yonei Y, Tanaka M, Ozawa Y, et al.. Primary hepatocellular carcinoma with severe hypoglycemia; involvement of insulin-like growth factors. Liver. 1992, 12:90-93. 10.1111\/j.1600-0676.1992.tb00563.x","journal-title":"Liver"},{"key":"ref15","article-title":"Hypoglycemia, the first presenting sign of hepatocellular carcinoma","volume":"27","author":"Nikeghbalian S","year":"2006","unstructured":"Nikeghbalian S, Bananzadeh A, Yarmohammadi H. Hypoglycemia, the first presenting sign of hepatocellular carcinoma. Saudi Med J. 2006, 27:387-388.","journal-title":"Saudi Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0680-3","article-title":"Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin","volume":"62","author":"Kampitak T","year":"2008","unstructured":"Kampitak T. Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin. Cancer Chemother Pharmacol. 2008, 62:929-930. 10.1007\/s00280-008-0680-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2010.09.003","article-title":"Hepatocellular carcinoma arising from ectopic liver tissue in the spleen producing insulin-like growth factor II","volume":"207","author":"Matsuyama M","year":"2011","unstructured":"Matsuyama M, Sugiura S, Kakita A, Sato Y, Kuroda M. Hepatocellular carcinoma arising from ectopic liver tissue in the spleen producing insulin-like growth factor II. Pathol Res Pract. 2011, 207:124-126. 10.1016\/j.prp.2010.09.003","journal-title":"Pathol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3915","article-title":"Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: a case report","volume":"11","author":"Huang JS","year":"2016","unstructured":"Huang JS, Chang PH. Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: a case report. Oncol Lett. 2016, 11:898-900. 10.3892\/ol.2015.3915","journal-title":"Oncol Lett"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0004","article-title":"Pro-IGF2-induced hypoglycaemia associated with hepatocellular carcinoma","volume":"2017","author":"van den Berg SAA","year":"2017","unstructured":"van den Berg SAA, Krol CG. Pro-IGF2-induced hypoglycaemia associated with hepatocellular carcinoma. Endocrinol Diabetes Metab Case Reports. 2017, 2017:17-0004. 10.1530\/EDM-17-0004","journal-title":"Endocrinol Diabetes Metab Case Reports"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i8.519","article-title":"Non-islet cell tumor hypoglycemia as an initial presentation of hepatocellular carcinoma coupled with end-stage liver cirrhosis: a case report and review of literature","volume":"12","author":"Yu B","year":"2020","unstructured":"Yu B, Douli R, Suarez JA, Gutierrez VP, Aldiabat M, Khan M. Non-islet cell tumor hypoglycemia as an initial presentation of hepatocellular carcinoma coupled with end-stage liver cirrhosis: a case report and review of literature. World J Hepatol. 2020, 12:519-524. 10.4254\/wjh.v12.i8.519","journal-title":"World J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45791-paraneoplastic-hypoglycemia-in-hepatocarcinoma-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:12Z","timestamp":1707506592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45791-paraneoplastic-hypoglycemia-in-hepatocarcinoma-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}